secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2026-05-11T23:59:59+00:00
Accession:  0001437749-26-016000
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical receives FDA clearance for power liposuction on AYON Body Contouring System
--------------------------------------------------------------------------------

- Expanded FDA 510(k) clearance for AYON Body Contouring System to include power liposuction, a reciprocating cannula for efficient fat removal.
- Power liposuction reduces surgeon effort and OR time; adds as second advanced liposuction modality on unified platform.
- Company plans limited commercial launch with early adopters to refine training and customer experience before scaling.
- CEO Charlie Goodwin says AYON becomes gold-standard system in surgical aesthetics with this clearance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000143774926016000/0001437749-26-016000-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000143774926016000/apyx20260508_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-016000

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer